Skip to main content
2025 STS Annual Meeting Main banner
Back

General Thoracic

Systemic Therapy Fundamentals: Back to the Basics... and Beyond

Targeted Therapy 101—How Does it Work?

Saturday, January 25, 2025
3:54pm – 4:02pm PT
Location: 408A

    Invited Speaker(s)

  • Narjust Florez, MD FASCO (she/her/hers)

    Thoracic Medical Oncology - Assistant Professor of Medicine
    Dana-Farber Cancer Institute - Harvard Medical School
    Boston, Massachusetts, United States

    Disclosure(s): Astra Zeneca: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Advisory Board (Ongoing); Daiichi-Sankyo: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Genentech: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Merck & Co.: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisory Board (Terminated); Novocure: Advisory Board (Ongoing); Pfizer: Advisory Board (Ongoing), Consultant (Ongoing)

Disclosure(s):
Narjust Florez, MD FASCO: Astra Zeneca: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Advisory Board (Ongoing); Daiichi-Sankyo: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Genentech: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Merck & Co.: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisory Board (Terminated); Novocure: Advisory Board (Ongoing); Pfizer: Advisory Board (Ongoing), Consultant (Ongoing)